The Novel HLA ‐A*02:1138 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual
HLA · 2024
DOI: 10.1111/tan.15779 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Juan Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Exons, HLA-A2 Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: National Key R&D Program of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
HLA‐A*02:1138 differs from HLA‐A*02:03:01:01 by one nucleotide in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Shanghai Tissuebank Biotechnology Co. Ltd, Shanghai, China.
ORCID-Profile: Xiaoning Wang
Förderung
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Ren, J., Xie, Z., Zheng, E., Zhou, Y., & Wang, X. (2024). The Novel HLA ‐A*02:1138 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual. HLA. https://doi.org/10.1111/tan.15779
Vancouver
Ren J, Xie Z, Zheng E, Zhou Y, Wang X. The Novel HLA ‐A*02:1138 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual. HLA. 2024. doi:10.1111/tan.15779
BibTeX
@article{Ren2024,
author = {Ren, Juan and Xie, Zhicong and Zheng, Endong and Zhou, Ying and Wang, Xiaoning},
title = {The Novel HLA ‐A*02:1138 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15779}
}
EUVIMED